ARTA
ATHE

A.R.T. Advisors’s Alterity Therapeutics ATHE Stock Holding History

A.R.T. Advisors’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-565
Closed -$24K – 1347
2015
Q4 		$24K Buy
+565
New +$28.7K ﹤0.01% 1407
2014
Q4 		– Sell
-1,370
Closed -$175K – 1410
2014
Q3 		$175K Buy
+1,370
New +$183K 0.01% 1129
2013
Q3 		– Sell
-223
Closed -$31K – 1292
2013
Q2 		$31K Buy
+223
New +$30.3K ﹤0.01% 1291

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

A.R.T. Advisors's ATHE Position: Q1 2016 in Review

A.R.T. Advisors sold out of Alterity Therapeutics (ATHE) in Q1 2016, closing a stake of 565 shares — an estimated $24K sold.

A.R.T. Advisors first reported a position in ATHE in Q2 2013 and held it in 3 quarters. The position peaked at $175K in Q3 2014. 14 funds tracked by Wall St. Rank hold ATHE as of Q1 2016.

  • A.R.T. Advisors reported no remaining Alterity Therapeutics position as of Q1 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 565 Alterity Therapeutics shares in Q1 2016, an estimated $24K.
  • A.R.T. Advisors first reported a position in Alterity Therapeutics in Q2 2013 and held it in 3 quarters.
  • A.R.T. Advisors's Alterity Therapeutics position peaked at $175K in Q3 2014.
  • 14 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2016.

Based on A.R.T. Advisors's 13F filing for Q1 2016, filed 16 May 2016.